Oncobit
Schlieren, Switzerland
Oncobit is a MedTech spin-off from the University of Zurich, developing precision diagnostic and monitoring assays for personalized cancer care. Oncobit's products aim to provide a detailed understanding of genomic cancer alterations throughout the patient's treatment history. Highly sensitive diagnostic and monitoring tools allow Oncobit to propose the most relevant treatment options and to help physicians improve the therapies they provide their patients. Oncobit is addressing the rapidly expanding market of precision oncology and personalized disease monitoring with non-invasive and highly precise technologies. The company is currently focused on melanoma, but Oncobits approach is data-centric, modular, and expandable to other cancer types in the future.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- oncobit.com/en/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Oncobit?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now